Published online Jan 6, 2024. doi: 10.12998/wjcc.v12.i1.217
Peer-review started: October 30, 2023
First decision: November 21, 2023
Revised: November 30, 2023
Accepted: December 19, 2023
Article in press: December 19, 2023
Published online: January 6, 2024
Processing time: 63 Days and 15.9 Hours
Addison’s disease (AD) is a rare but potentially fatal disease in Western countries, which can easily be misdiagnosed at an early stage. Severe adrenal tuberculosis (TB) may lead to depression in patients.
We report a case of primary adrenal insufficiency secondary to adrenal TB with TB in the lungs and skin in a 48-year-old woman. The patient was misdiagnosed with depression because of her depressed mood. She had hyperpigmentation of the skin, nails, mouth, and lips. The final diagnosis was adrenal TB that resulted in the insufficient secretion of adrenocortical hormone. Adrenocortical hormone test, skin biopsy, T cell spot test of TB, and adrenal computed tomography scan were used to confirm the diagnosis. The patient’s condition improved after hormone replacement therapy and TB treatment.
Given the current status of TB in high-burden countries, outpatient doctors should be aware of and pay attention to TB and understand the early symptoms of AD.
Core Tip: Symptoms of early-onset depressed mood and skin pigmentation in developing countries warrant consideration for Addison’s disease (AD) induced by adrenal tuberculosis (TB) Diagnostic anti-TB therapy with rifampicin is not recommended because of the risk of adrenal crisis; T cell spot test of TB negativity cannot be used as a criterion to exclude TB, especially in immunocompromised patients or those with hematogenous disseminated pulmonary TB; In AD caused by adrenal TB, recovering adrenal function is difficult, with most cases requiring lifelong hormone replacement therapy.